Chemoinformaics analysis of 8-Formyl-2,5,7-trihydroxy-6-methylflavanone
Molecular Weight | 314.293 | nRot | 2 |
Heavy Atom Molecular Weight | 300.181 | nRig | 19 |
Exact Molecular Weight | 314.079 | nRing | 3 |
Solubility: LogS | -3.55 | nHRing | 1 |
Solubility: LogP | 2.876 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
nHA | 6 | APOL | 42.5371 |
nHD | 3 | BPOL | 17.5169 |
QED | 0.733 |
Synth | 3.436 |
Natural Product Likeliness | 1.828 |
NR-PPAR-gamma | 0.847 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.005 |
Pgp-sub | 0 |
HIA | 0.022 |
CACO-2 | -5.015 |
MDCK | 0.0000148 |
BBB | 0.226 |
PPB | 0.956413 |
VDSS | 0.736 |
FU | 0.0180392 |
CYP1A2-inh | 0.316 |
CYP1A2-sub | 0.166 |
CYP2c19-inh | 0.092 |
CYP2c19-sub | 0.222 |
CYP2c9-inh | 0.265 |
CYP2c9-sub | 0.726 |
CYP2d6-inh | 0.074 |
CYP2d6-sub | 0.203 |
CYP3a4-inh | 0.149 |
CYP3a4-sub | 0.278 |
CL | 3.716 |
T12 | 0.276 |
hERG | 0.008 |
Ames | 0.038 |
ROA | 0.124 |
SkinSen | 0.829 |
Carcinogencity | 0.144 |
EI | 0.419 |
Respiratory | 0.44 |
NR-Aromatase | 0.819 |
Antiviral | Yes |
Prediction | 0.840444 |